Back

Clinical perspectives: raising suspicion and diagnosing ATTR-CM in patients with heart failure.

22 May 2022 (15:00 - 15:15)
Organised by:
Congress Presentation Part of: Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)? Cardiac Diseases Open Access Heart Failure 2022

About the speaker

Photo
Associate Professor Arthur Pollak

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)

3 More presentations in this session

Presentation thumbnail
Heart failure or ATTR-CM? The importance of early diagnosis.
Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES)
Presentation thumbnail
Long-term management of patients with ATTR-CM.
Professor C. Rapezzi (Ferrara, IT)
Slides Video
Presentation thumbnail
Panel discussion and Q&A.
Slides Video

Access the full session

Session thumbnail
Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)?

The Event

Event poster

Heart Failure 2022

22 May 2022 15:00 CET
You may be interested in
thumbnail
Congress Session
The many faces of transthyretin amyloidosis cardiomyopathy
12 May 2026
thumbnail
Congress Presentation
Diagnosis of the different types of amyloidosis
22 May 2023
thumbnail
Congress Presentation
Emerging trends in the clinical practice of transthyretin amyloid cardiomyopathy (ATTR-CM)
28 August 2023
thumbnail
Congress Presentation
A patient with cardiac amyloidosis
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources